Tom Degenhardt

West German Study Group Phase III PlanB Trial: First Prospective Outcome Data for the 21-Gene Recurrence Score Assay and Concordance of Prognostic Markers by Central and Local Pathology Assessment

Oleg Gluz, Ulrike Nitz, Matthias Christgen et al. · Journal of Clinical Oncology · 2016 · 366 citations

Medicine, Oncology, Breast Oncology +16

Significantly longer time to deterioration of quality of life due to CANKADO PRO-React eHealth support in HR+ HER2− metastatic breast cancer patients receiving palbociclib and endocrine therapy: primary outcome analysis of the multicenter randomized AGO-B WSG PreCycle trial

Nadia Harbeck, Peter A. Fasching, Rachel Wuerstlein et al. · Annals of Oncology · 2023 · 41 citations · Full text

Medicine, Oncology, Pharmacology +17

Heterogeneity of bone metastases as an important prognostic factor in patients affected by oestrogen receptor-positive breast cancer. The role of combined [18F]Fluoroestradiol PET/CT and [18F]Fluorodeoxyglucose PET/CT

Gianluca Bottoni, Arnoldo Piccardo, Francesco Fiz et al. · European Journal of Radiology · 2021 · 31 citations · Full text

Medicine, Nuclear Medicine, Oncology +16

COVID-19 vaccination in patients with breast cancer and gynecological malignancies: A German perspective

Rachel Wuerstlein, Alexander Köenig, Niklas Amann et al. · The Breast · 2021 · 24 citations · Full text

Veterinary Medicine, Oncology, Pharmacotherapy +17

Influence of HER2 expression on prognosis in metastatic triple-negative breast cancer—results from an international, multicenter analysis coordinated by the AGMT Study Group

Simon Peter Gampenrieder, Vincent O. Dezentjé, Matteo Lambertini et al. · ESMO Open · 2022 · 22 citations · Full text

Medicine, Cancer Biology, Oncology +16